[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370297-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370297-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-insights-into-hr-hpv-and-hcmv-co-presence-in-cervical-cancer-development-review","Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development - review","","High-risk human papillomavirus (HR-HPV) infection is the primary cause of most cervical cancer cases, yet HR-HPV alone does not fully explain cervical carcinogenesis, indicating the involvement of additional co-factors. Human cytomegalovirus (HCMV), commonly detected in cervical lesions, has demonstrated oncogenic potential. This review evaluates molecular interactions between HR-HPV and HCMV and synthesizes evidence from selected studies to describe shared and synergistic mechanisms that may support tumor progression, immune evasion, and lesion persistence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-insights-into-hr-hpv-and-hcmv-co-presence-in-cervical-cancer-development-review/370297/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-insights-into-hr-hpv-and-hcmv-co-presence-in-cervical-cancer-development-review/370297.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is HR-HPV considered necessary but not sufficient for cervical cancer development?","Question",{"text":63,"@type":64},"Although HR-HPV is recognized as the main cause of cervical cancer, evidence indicates that HR-HPV infection alone may not be sufficient to drive carcinogenesis, implying additional co-factors are needed.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does HCMV potentially play in cervical cancer?",{"text":68,"@type":64},"HCMV, often detected in cervical cancer samples, may amplify cancer-related processes by disrupting cellular stability, weakening immune defenses, and promoting ongoing malignant transformation.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the review’s conclusions describe the interaction between HR-HPV and HCMV?",{"text":72,"@type":64},"The review concludes that both viruses may synergistically promote epithelial transformation and tumor progression through overlapping oncogenic mechanisms, including facilitation of viral entry and cooperative disruption of cellular and immune processes, while noting the need for further in vitro and in vivo validation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370297,1790793754,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nMolecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development  \nRancés Blanco 1, * and Juan P. Muñoz 2, *  \nAcademic Editors: Academic Editors: Ronen Borenstein and Yosef Sabo  \nReceived: 27 September 2024  \nRevised: 27 October 2024  \nAccepted: 3 November 2024  \nPublished: 8 February 2025  \nCitation: Blanco, R.; Muñoz, J.P. Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development. Cancers 2025, 17, 582. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers17040582  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Independent Researcher, Av. Vicuña Mackenna Poniente 6315, La Florida 8240000, Chile  \n2 Laboratorio de Bioquímica, Departamento de Química, Facultad de Ciencias, Universidad de Tarapacá, Arica 1000007, Chile  \n* Correspondence: [rancesblanco1976@gmail.com](rancesblanco1976@gmail.com) (R.B.); [jpmunozb@academicos.uta.cl](jpmunozb@academicos.uta.cl) (J.P.M.); Tel.: +56-582386199 (J.P.M.)  \nSimple Summary: High-risk human papillomavirus (HR-HPV) infection is recognized asthe primary cause of nearly all cervical cancer cases. However, the evidence suggests that HPV alone may not be sufficient to drive cervical carcinogenesis, pointing to additional co-factors. Notably, recent findings highlight that human cytomegalovirus (HCMV), aherpesvirus commonly detected in cervical lesions, may amplify cancer-related processes. This review examines the current literature on the possible synergistic role of HR-HPV and HCMV in cervical cancer development. The literature reviewed suggests that HCMV could work alongside HR-HPV to disrupt cellular stability, weaken immune defenses, and promote ongoing malignant transformation, potentially accelerating cervical carcinogenesis.  \nAbstract: Background: Cervical cancer remains a significant health concern worldwide and the primary cause of cancerous cervical lesions is the infection with high-risk human papillomavirus (HR-HPV) . However, emerging evidence suggests that HR-HPV infection alone is insufficient for cancer development, and other co-factors may contribute to cervical carcinogenesis. Human cytomegalovirus (HCMV), a common herpesvirus frequently detected in cervical cancer samples, has demonstrated oncogenic potential. Objectives: This review aims to explore the molecular interactions between HR-HPV and HCMV in promoting cervical cancer progression. Methods. A comprehensive search was conducted in PubMed and Google Scholar, focusing on articles examining the role of HCMV in cervical tissues and/or cells, selected based on relevance and significance. Results: The reviewed literature indicates that HCMV and HR-HPV share several oncogenic mechanisms that could drive cervical cell transformation. Conclusions. Both viruses may synergistically promote cervical epithelial transformation and tumor progression in multiple ways. HR-HPV may facilitate HCMV entry by increasing host cell receptors essential for viral attachment. Additionally, HR-HPV and HCMV may cooperatively disrupt cellular processes, enhancing carcinogenesis. Both viruses may also modulate the local immune environment, enabling immune evasion and lesion persistence. However, further in vitro and in vivo studies are required to validate these hypotheses.  \nKeywords: human papillomavirus; HPV; human cytomegalovirus; HCMV; oncoproteins; cervical cancer  \n1. Introduction  \nUterine cervix cancer remains a significant global health concern. In 2022, an estimated 661,021 new cases and approximately 348,189 deaths were attributed to this disease  \nworldwide [1] . Although the overall incidence of cervical cancer has declined or stabilizedin many regions du","cbCaiqY1SMHP1RFf","https://ap.wps.com/l/cbCaiqY1SMHP1RFf","pdf",1052189,18,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why is HR-HPV considered necessary but not sufficient for cervical cancer development?\",\"answer\":\"Although HR-HPV is recognized as the main cause of cervical cancer, evidence indicates that HR-HPV infection alone may not be sufficient to drive carcinogenesis, implying additional co-factors are needed.\"},{\"question\":\"What role does HCMV potentially play in cervical cancer?\",\"answer\":\"HCMV, often detected in cervical cancer samples, may amplify cancer-related processes by disrupting cellular stability, weakening immune defenses, and promoting ongoing malignant transformation.\"},{\"question\":\"How do the review’s conclusions describe the interaction between HR-HPV and HCMV?\",\"answer\":\"The review concludes that both viruses may synergistically promote epithelial transformation and tumor progression through overlapping oncogenic mechanisms, including facilitation of viral entry and cooperative disruption of cellular and immune processes, while noting the need for further in vitro and in vivo validation.\"}]","Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development - review | PDF",1790187843,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ab5dc4d2cf68e43c327f392d0337e53.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db0c29939104199ab8eb6c93a110f22f.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6e98bdd06284d434a58775df94e775f.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21835082c2e4a3d600b3352653ad8797.webp",980,1385]